Tenax Therapeutics Inc. (TENX)
6.00
-0.30 (-4.76%)
At close: Apr 03, 2025, 3:59 PM
6.31
5.13%
Pre-market: Apr 04, 2025, 08:20 AM EDT
Tenax Therapeutics Inc. Revenue Breakdown
| Quarter | Jan 31, 2013 |
|---|---|
| United States Revenue | 2.87K |
| United States Revenue Growth | n/a |
Revenue by Geography
| Quarter | Apr 30, 2013 |
|---|---|
| Europe Revenue | 46.67K |
| Europe Revenue Growth | n/a |
| United States Revenue | 46.02K |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.51M | 1.34M | 1.23M | 1.64M | 1.05M | 1.04M | 1.27M | 1.42M | 1.38M | 1.34M | 1.54M | 2.3M | 2.64M | 1.27M | 1.37M | 1.94M | 1.17M | 869.21K | 1.32M | 1.39M | 1.34M | 1.17M | 1.18M | 1.72M | 1.19M | 1.58M | 1.16M | 1.39M | 1.05M | 1.79M | 1.45M | 1.98M | 1.27M | 1.24M | 1.76M | 933.62K | 1M | 1.37M | 2.82M | 1.66M |
| Selling, General, and Administrative Revenue Growth | +12.08% | +9.06% | -24.70% | +55.67% | +1.28% | -18.49% | -10.29% | +3.09% | +2.98% | -13.20% | -32.90% | -13.02% | +107.66% | -7.44% | -29.29% | +65.62% | +34.92% | -34.30% | -4.91% | +3.56% | +14.78% | -0.73% | -31.46% | +44.36% | -24.36% | +35.52% | -16.45% | +32.00% | -41.17% | +23.76% | -26.85% | +56.31% | +2.12% | -29.63% | +88.69% | -6.65% | -26.92% | -51.40% | +69.17% | n/a |
| Research and Development Revenue | 3.11M | 2.33M | 2.68M | 1.7M | 1.07M | 197.9K | 265.74K | 1.13M | 1.54M | 1.52M | 1.18M | 915.6K | 1.16M | 693.22K | 22.38M | 890.96K | 1.05M | 1.27M | 1.34M | 1.42M | 916.98K | 649.25K | 482.77K | 506.94K | 362.63K | 311.15K | 58.59K | -1.02K | 253.97K | 1.22M | 2.05M | 2.53M | 3.23M | 3.43M | 3.94M | 4.52M | 2.52M | 1.75M | 1.91M | 1.23M |
| Research and Development Revenue Growth | +33.70% | -13.01% | +57.45% | +59.43% | +438.57% | -25.53% | -76.58% | -26.32% | +1.03% | +29.42% | +28.65% | -21.23% | +67.68% | -96.90% | +2411.46% | -15.34% | -17.45% | -5.04% | -5.60% | +55.09% | +41.24% | +34.49% | -4.77% | +39.79% | +16.54% | +431.08% | -5838.30% | -100.40% | -79.23% | -40.39% | -18.91% | -21.79% | -5.74% | -12.98% | -12.73% | +79.42% | +44.26% | -8.58% | +55.63% | n/a |